Ground-breaking work from laboratories around the world has established that the metabolism of cancer cells is central to the control of tumour growth. Indeed, malignant cells and their normal counterparts engage different metabolic pathways, offering potential therapeutic opportunities for cancer treatment. Moreover, a complex network of metabolic interactions between cancer and non-malignant cells contributes to an aberrant metabolic landscape that may prevail in cancer patients. This meeting will provide a topical view of the metabolic vulnerabilities of cancer cells and how the interplay between tumour, stroma and systemic metabolism contributes to cancer progression and highlights opportunities for cancer treatment and prevention.
For mor information please go to: http://www.beatson.gla.ac.uk/Beatson-Conference/beatson-international-cancer-conference.html